Benzinga | Jul 29, 2021 07:26AM EDT

Agios Pharmaceuticals Q2 EPS $(1.41), Inline

Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.41) per share which met the analyst consensus estimate. This is a 7.63 percent decrease over losses of $(1.31) per share from the same period last year.